Other Species / Isoforms
  MARVELD2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y14-p
SRNRDRRyDEVPSDL
Upstream
0 50
Treatment
  • ephrin_B1
MARVELD2 (human) SRNRDRRyDEVPSDL Y14-p
MARVELD2 iso2 (human) SRNRDRRYDEVPSDL Y14
MARVELD2 (mouse) SRIRDRGySEVPRDT Y15-p
MARVELD2 (rat) SRIRDRDYSEVPRDS Y15
Y23-p
EVPSDLPyQDttIRT
Upstream
0 60
Treatment
  • EGF
MARVELD2 (human) EVPSDLPyQDttIRT Y23-p
MARVELD2 iso2 (human) EVPSDLPYQDTTIRT Y23
MARVELD2 (mouse) EVPRDTSCPDGTIRT C24
MARVELD2 (rat) EVPRDSPCPDGIVRT C24
T26-p
SDLPyQDttIRTHPT
0 1
MARVELD2 (human) SDLPyQDttIRTHPT T26-p
MARVELD2 iso2 (human) SDLPYQDTTIRTHPT T26
MARVELD2 (mouse) RDTSCPDGTIRTFQS G27
MARVELD2 (rat) RDSPCPDGIVRTLQS G27
T27-p
DLPyQDttIRTHPTL
0 2
MARVELD2 (human) DLPyQDttIRTHPTL T27-p
MARVELD2 iso2 (human) DLPYQDTTIRTHPTL T27
MARVELD2 (mouse) DTSCPDGTIRTFQSL T28
MARVELD2 (rat) DSPCPDGIVRTLQSL I28
S37-p
THPTLHDsERAVSAD
0 2
MARVELD2 (human) THPTLHDsERAVSAD S37-p
MARVELD2 iso2 (human) THPTLHDSERAVSAD S37
MARVELD2 (mouse) TFQSLHSSELAVSAD S38
MARVELD2 (rat) TLQSLHSSELAVSAD S38
K87-ub
RFVPDSWkNFFRGKK
0 1
MARVELD2 (human) RFVPDSWkNFFRGKK K87-ub
MARVELD2 iso2 (human) RFVPDSWKNFFRGKK K87
MARVELD2 (mouse) RFVPDSWKNFFRGKK K88
MARVELD2 (rat) RFVPDSWKNFFRGKK K88
K101-ub
KKDPEWDkPVsDIRY
0 1
MARVELD2 (human) KKDPEWDkPVsDIRY K101-ub
MARVELD2 iso2 (human) KKDPEWDKPVSDIRY K101
MARVELD2 (mouse) KKDPEWDNPVSDIRY N102
MARVELD2 (rat) KKDPEWDKPVSDIRY K102
S104-p
PEWDkPVsDIRYISD
0 1
MARVELD2 (human) PEWDkPVsDIRYISD S104-p
MARVELD2 iso2 (human) PEWDKPVSDIRYISD S104
MARVELD2 (mouse) PEWDNPVSDIRYISD S105
MARVELD2 (rat) PEWDKPVSDIRYISD S105
S116-p
ISDGVECsPPAsPAR
0 17
MARVELD2 (human) ISDGVECsPPAsPAR S116-p
MARVELD2 iso2 (human) ISDGVECSPPASPAR S116
MARVELD2 (mouse) ISDGVECsPPAsPAR S117-p
MARVELD2 (rat) ISDGVECSPPASPAR S117
S120-p
VECsPPAsPARPNHR
0 15
MARVELD2 (human) VECsPPAsPARPNHR S120-p
MARVELD2 iso2 (human) VECSPPASPARPNHR S120
MARVELD2 (mouse) VECsPPAsPARANHH S121-p
MARVELD2 (rat) VECSPPASPARPNHH S121
S128-p
PARPNHRsPLNSCkD
0 1
MARVELD2 (human) PARPNHRsPLNSCkD S128-p
MARVELD2 iso2 (human) PARPNHRSPLNSCKD S128
MARVELD2 (mouse) gap -
MARVELD2 (rat) PARPNHHPPNSYKDP P129
K134-ub
RsPLNSCkDPyGGsE
0 3
MARVELD2 (human) RsPLNSCkDPyGGsE K134-ub
MARVELD2 iso2 (human) RSPLNSCKDPYGGSE K134
MARVELD2 (mouse) RANHHPYKDPSRGSQ K131
MARVELD2 (rat) HHPPNSYKDPSGGSQ K134
Y137-p
LNSCkDPyGGsEGTF
0 5
MARVELD2 (human) LNSCkDPyGGsEGTF Y137-p
MARVELD2 iso2 (human) LNSCKDPYGGSEGTF Y137
MARVELD2 (mouse) HHPYKDPSRGSQGTF S134
MARVELD2 (rat) PNSYKDPSGGSQGTF S137
S140-p
CkDPyGGsEGTFSsR
0 4
MARVELD2 (human) CkDPyGGsEGTFSsR S140-p
MARVELD2 iso2 (human) CKDPYGGSEGTFSSR S140
MARVELD2 (mouse) YKDPSRGSQGTFNSQ S137
MARVELD2 (rat) YKDPSGGSQGTFDSQ S140
S146-p
GsEGTFSsRkEADAV
0 1
MARVELD2 (human) GsEGTFSsRkEADAV S146-p
MARVELD2 iso2 (human) GSEGTFSSRKEADAV S146
MARVELD2 (mouse) GSQGTFNSQHEADAM S143
MARVELD2 (rat) GSQGTFDSQQEADAM S146
K148-ub
EGTFSsRkEADAVFP
0 1
MARVELD2 (human) EGTFSsRkEADAVFP K148-ub
MARVELD2 iso2 (human) EGTFSSRKEADAVFP K148
MARVELD2 (mouse) QGTFNSQHEADAMFA H145
MARVELD2 (rat) QGTFDSQQEADAMFP Q148
Y159-p
AVFPRDPyGsLDRHt
0 1
MARVELD2 (human) AVFPRDPyGsLDRHt Y159-p
MARVELD2 iso2 (human) AVFPRDPYGSLDRHT Y159
MARVELD2 (mouse) AMFAHDPYAsLDRRT Y156
MARVELD2 (rat) AMFPHDPYASLDRRT Y159
S161-p
FPRDPyGsLDRHtQt
Upstream
0 16
Treatment
  • metformin
MARVELD2 (human) FPRDPyGsLDRHtQt S161-p
MARVELD2 iso2 (human) FPRDPYGSLDRHTQT S161
MARVELD2 (mouse) FAHDPYAsLDRRTQT S158-p
MARVELD2 (rat) FPHDPYASLDRRTQT S161
T166-p
yGsLDRHtQtVRTYs
Upstream
0 4
Treatment
  • metformin
MARVELD2 (human) yGsLDRHtQtVRTYs T166-p
MARVELD2 iso2 (human) YGSLDRHTQTVRTYS T166
MARVELD2 (mouse) YAsLDRRTQTARTYs T163
MARVELD2 (rat) YASLDRRTQTARTYS T166
T168-p
sLDRHtQtVRTYsEk
0 2
MARVELD2 (human) sLDRHtQtVRTYsEk T168-p
MARVELD2 iso2 (human) SLDRHTQTVRTYSEK T168
MARVELD2 (mouse) sLDRRTQTARTYsEk T165
MARVELD2 (rat) SLDRRTQTARTYSEK T168
S173-p
tQtVRTYsEkVEEYN
0 5
MARVELD2 (human) tQtVRTYsEkVEEYN S173-p
MARVELD2 iso2 (human) TQTVRTYSEKVEEYN S173
MARVELD2 (mouse) TQTARTYsEkVEEYN S170-p
MARVELD2 (rat) TQTARTYSEKVEEYN S173
K175-ub
tVRTYsEkVEEYNLR
0 4
MARVELD2 (human) tVRTYsEkVEEYNLR K175-ub
MARVELD2 iso2 (human) TVRTYSEKVEEYNLR K175
MARVELD2 (mouse) TARTYsEkVEEYNLR K172-ub
MARVELD2 (rat) TARTYSEKVEEYNLR K175
Y304-p
NVALFILyMAAAIVY
0 1
MARVELD2 (human) NVALFILyMAAAIVY Y304-p
MARVELD2 iso2 (human) NVALFILYMAAAIVY Y304
MARVELD2 (mouse) NVALFILYMAAAIVY Y301
MARVELD2 (rat) NVALFVLYMAAAIVY Y304
Y377-p
AARRHREyMEQQEIN
0 2
MARVELD2 (human) AARRHREyMEQQEIN Y377-p
MARVELD2 iso2 (human) AARRHREYMEQQEIN Y377
MARVELD2 (mouse) AARRHREFLEQQEIN F374
MARVELD2 (rat) AARKHREFMEQQEIN F377
S387-p
QQEINEPsLSSkRKM
0 4
MARVELD2 (human) QQEINEPsLSSkRKM S387-p
MARVELD2 iso2 (human) QQEINEPSLSSKRKM S387
MARVELD2 (mouse) QQEINDPSLSSkRKM S384
MARVELD2 (rat) QQEINDPSLSSKRRM S387
K391-ub
NEPsLSSkRKMCEMA
0 3
MARVELD2 (human) NEPsLSSkRKMCEMA K391-ub
MARVELD2 iso2 (human) NEPSLSSKRKMCEMA K391
MARVELD2 (mouse) NDPSLSSkRKMCEAA K388-ub
MARVELD2 (rat) NDPSLSSKRRMCEVA K391
S407-p
SGDRQRDsEVNFkEL
0 3
MARVELD2 (human) SGDRQRDsEVNFkEL S407-p
MARVELD2 iso2 (human) SGDRQRDSEVNFKEL S407
MARVELD2 (mouse) ISDRQRDQEVNVKDL Q403
MARVELD2 (rat) TSDRQKDQEVNFKEL Q406
K412-ub
RDsEVNFkELRTAKM
0 3
MARVELD2 (human) RDsEVNFkELRTAKM K412-ub
MARVELD2 iso2 (human) RDSEVNFKELRTAKM K412
MARVELD2 (mouse) RDQEVNVKDLRTTTK K408
MARVELD2 (rat) KDQEVNFKELRTTTK K411
Y442-p
KPIVMPDyVAKyPVI
0 2
MARVELD2 (human) KPIVMPDyVAKyPVI Y442-p
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) KPIVMPDYVAKYPVI Y439
MARVELD2 (rat) KPIVMPDYVAKYPVI Y442
Y446-p
MPDyVAKyPVIQTDD
0 1
MARVELD2 (human) MPDyVAKyPVIQTDD Y446-p
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) MPDYVAKYPVIQTDD Y443
MARVELD2 (rat) MPDYVAKYPVIQTDD Y446
S467-p
AVFQDQFsEyKELSA
0 2
MARVELD2 (human) AVFQDQFsEyKELSA S467-p
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) AVFQDQFSEYKELSA S464
MARVELD2 (rat) AVFQDQFSEYKELSA S467
Y469-p
FQDQFsEyKELSAEV
Upstream
0 14
Treatment
  • Su11274
MARVELD2 (human) FQDQFsEyKELSAEV Y469-p
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) FQDQFSEYKELSAEV Y466
MARVELD2 (rat) FQDQFSEYKELSAEV Y469
K482
EVQAVLRKFDELDAV
0 1
MARVELD2 (human) EVQAVLRKFDELDAV K482
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) EVQAILRkFDELDTV K479-ub
MARVELD2 (rat) EVQATLRKFDELDTV K482
K548-ub
QRIQEYDkVMNWDVQ
0 1
MARVELD2 (human) QRIQEYDkVMNWDVQ K548-ub
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) QRIQEYDKVMNWDTQ K545
MARVELD2 (rat) QRIQEYDKVMNWDTQ K548
Y557-p
MNWDVQGys______
Upstream
0 4
Treatment
  • gefitinib
  • Su11274
MARVELD2 (human) MNWDVQGys______ Y557-p
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) MNWDTQGYP______ Y554
MARVELD2 (rat) MNWDTQGYP______ Y557
S558-p
NWDVQGys_______
0 1
MARVELD2 (human) NWDVQGys_______ S558-p
MARVELD2 iso2 (human) gap -
MARVELD2 (mouse) NWDTQGYP_______ P555
MARVELD2 (rat) NWDTQGYP_______ P558